Author: Laila Zulfa

The medical technology landscape for end-stage renal disease (ESRD) has reached a significant milestone as Medtronic recently unveiled positive results from its post-approval study of the IN.PACT AV drug-coated balloon (DCB). Presented at the Society of Interventional Radiology’s (SIR) annual meeting, the data reinforces the long-term safety and clinical efficacy of the device, matching the…

Boston Scientific Corporation has announced a major strategic investment of €75 million to expand its research, development, and manufacturing operations in Galway, Ireland, signaling a significant commitment to the next generation of cardiovascular medical technologies. The investment is designed to enhance the site’s capacity to develop sophisticated solutions for some of the most complex challenges…

The global healthcare leader Abbott Laboratories has officially entered a transformative era in its diagnostic portfolio following the monumental $21 billion acquisition of Exact Sciences, a move that has prompted a recalibration of the company’s financial outlook for the 2026 fiscal year. During its first-quarter earnings presentation on Thursday, April 16, 2026, Abbott reported a…

Avanos Medical, a prominent player in the specialty medical technology sector, has entered into a definitive agreement to be acquired by the private equity firm American Industrial Partners (AIP), marking a significant shift in the company’s corporate trajectory as it moves from the public markets into a private ownership structure. The deal comes at a…

U.S. Customs and Border Protection (CBP) has officially confirmed that it will launch its dedicated electronic refund system for tariffs previously collected under the International Emergency Economic Powers Act (IEEPA) on April 20 at 8:00 a.m. EDT. This announcement, detailed in a Tuesday filing with the Court of International Trade, marks a pivotal moment for…

Stereotaxis, a global leader in innovative magnetic navigation robotics for minimally invasive endovascular surgery, has entered into a definitive agreement to acquire Robocath, a privately held French developer of robotic systems for interventional vascular procedures. The acquisition marks a transformative milestone for Stereotaxis as it seeks to integrate its proprietary magnetic navigation technology with Robocath’s…

Endovascular Engineering, a medical technology firm focused on the treatment of venous thromboembolism, has successfully closed a Series C financing round intended to accelerate the development and commercialization of its proprietary HÄlo system. This latest injection of capital arrives at a pivotal moment for the mechanical thrombectomy sector, which has recently witnessed multi-billion-dollar consolidations and…

Medline Industries, LP, a prominent global manufacturer and distributor of medical supplies, has initiated a comprehensive market removal of specific angiographic syringes following a series of reports detailing mechanical failures that pose significant risks to both patients and healthcare providers. The recall, which specifically targets the Namic angiographic rotating adaptor control syringes, was triggered by…

The strategic realignment of Johnson & Johnson’s medical technology division toward high-growth, high-margin sectors has yielded significant dividends in the first quarter of 2026. According to the company’s latest financial disclosures, the medtech segment reported a total revenue of $8.64 billion, marking a 7.7% increase compared to the same period in the previous year. While…

The integrity of a sterile barrier system is the final line of defense between a life-saving medical device and the potential for life-threatening microbial contamination. In the high-stakes environment of medical device manufacturing, the failure of a sterile barrier rarely presents itself as a catastrophic rupture; instead, it often manifests in subtle, intermittent ways that…